Ameriprise
AMED

Ameriprise’s Amedisys AMED Stock Holding History

Ameriprise’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,470
Closed -$4.28M – 4057
2025
Q2 		$4.28M Buy
43,470
+3,257
+8% +$308K ﹤0.01% 2480
2025
Q1 		$3.72M Buy
40,213
+2,204
+6% +$203K ﹤0.01% 2525
2024
Q4 		$3.45M Buy
38,009
+4,146
+12% +$381K ﹤0.01% 2624
2024
Q3 		$3.27M Sell
33,863
-11,324
-25% -$1.1M ﹤0.01% 2647
2024
Q2 		$4.15M Sell
45,187
-6,394
-12% -$593K ﹤0.01% 2446
2024
Q1 		$4.75M Sell
51,581
-773
-1% -$72.4K ﹤0.01% 2411
2023
Q4 		$4.98M Buy
52,354
+13,722
+36% +$1.28M ﹤0.01% 2353
2023
Q3 		$3.61M Sell
38,632
-414,756
-91% -$38.3M ﹤0.01% 2518
2023
Q2 		$41.5M Sell
453,388
-358,710
-44% -$29.4M 0.01% 851
2023
Q1 		$59.7M Sell
812,098
-270,594
-25% -$23.4M 0.02% 667
2022
Q4 		$90.4M Buy
1,082,692
+2,507
+0.2% +$226K 0.03% 507
2022
Q3 		$105M Sell
1,080,185
-96,153
-8% -$11.5M 0.04% 442
2022
Q2 		$124M Sell
1,176,338
-342,438
-23% -$43.7M 0.04% 411
2022
Q1 		$262M Sell
1,518,776
-203,875
-12% -$30.5M 0.08% 272
2021
Q4 		$279M Buy
1,722,651
+126,013
+8% +$20.3M 0.08% 272
2021
Q3 		$238M Buy
1,596,638
+449,564
+39% +$93.5M 0.08% 276
2021
Q2 		$281M Buy
1,147,074
+348,767
+44% +$91.5M 0.09% 242
2021
Q1 		$211M Buy
798,307
+263,329
+49% +$74.3M 0.07% 290
2020
Q4 		$157M Buy
534,978
+9,622
+2% +$2.47M 0.06% 348
2020
Q3 		$124M Buy
525,356
+66,596
+15% +$15.1M 0.05% 368
2020
Q2 		$91.1M Sell
458,760
-22,040
-5% -$4.11M 0.04% 420
2020
Q1 		$88.2M Buy
480,800
+146,763
+44% +$26.1M 0.05% 367
2019
Q4 		$55.8M Buy
334,037
+20,253
+6% +$3.01M 0.02% 645
2019
Q3 		$41.1M Buy
313,784
+76,129
+32% +$9.91M 0.02% 756
2019
Q2 		$28.9M Sell
237,655
-218,412
-48% -$25.9M 0.01% 931
2019
Q1 		$56.2M Sell
456,067
-7,384
-2% -$927K 0.03% 601
2018
Q4 		$54.3M Sell
463,451
-447,474
-49% -$52.7M 0.03% 577
2018
Q3 		$114M Sell
910,925
-216,372
-19% -$23.9M 0.04% 413
2018
Q2 		$96.3M Buy
1,127,297
+314,000
+39% +$23.1M 0.04% 421
2018
Q1 		$49.1M Buy
813,297
+612,175
+304% +$34.9M 0.02% 666
2017
Q4 		$10.6M Buy
201,122
+23,586
+13% +$1.24M ﹤0.01% 1571
2017
Q3 		$9.93M Buy
177,536
+6,044
+4% +$320K ﹤0.01% 1587
2017
Q2 		$10.8M Buy
171,492
+24,458
+17% +$1.42M 0.01% 1495
2017
Q1 		$7.51M Buy
147,034
+6,674
+5% +$318K ﹤0.01% 1730
2016
Q4 		$5.98M Buy
140,360
+1,800
+1% +$76.5K ﹤0.01% 1893
2016
Q3 		$6.57M Sell
138,560
-35,715
-20% -$1.78M ﹤0.01% 1785
2016
Q2 		$8.8M Buy
174,275
+28,472
+20% +$1.44M 0.01% 1491
2016
Q1 		$7.05M Buy
145,803
+1,651
+1% +$63.7K ﹤0.01% 1713
2015
Q4 		$5.67M Sell
144,152
-2,778
-2% -$111K ﹤0.01% 1923
2015
Q3 		$5.58M Sell
146,930
-12,812
-8% -$540K ﹤0.01% 1938
2015
Q2 		$6.35M Buy
159,742
+2,637
+2% +$82.2K ﹤0.01% 1972
2015
Q1 		$4.21M Buy
157,105
+4,682
+3% +$132K ﹤0.01% 2200
2014
Q4 		$4.47M Buy
152,423
+6,411
+4% +$158K ﹤0.01% 2122
2014
Q3 		$2.94M Sell
146,012
-10,218
-7% -$197K ﹤0.01% 2335
2014
Q2 		$2.62M Buy
156,230
+7,386
+5% +$105K ﹤0.01% 2419
2014
Q1 		$2.22M Buy
148,844
+20,230
+16% +$311K ﹤0.01% 2446
2013
Q4 		$1.88M Buy
128,614
+391
+0.3% +$6.3K ﹤0.01% 2489
2013
Q3 		$2.21M Buy
128,223
+5,102
+4% +$75.7K ﹤0.01% 2392
2013
Q2 		$1.43M Buy
+123,121
New +$1.41M ﹤0.01% 2493

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameriprise's AMED Position: Q3 2025 in Review

Ameriprise sold out of Amedisys (AMED) in Q3 2025, closing a stake of 43,470 shares — an estimated $4.28M sold.

Ameriprise first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $281M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Ameriprise reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Ameriprise sold 43,470 Amedisys shares in Q3 2025, an estimated $4.28M.
  • Ameriprise first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Ameriprise's Amedisys position peaked at $281M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.